| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/07/2009 | US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 04/07/2009 | US7514397 Administering homologs of peptides corresponding to amino acid residues 638 to 673, and to amino acid residues 558 to 595, of the human immunodeficiency virus-1LAI transmembrane protein glycoprotein 41; inhibiting membrane fusion |
| 04/07/2009 | US7514243 Process for producing dipeptides |
| 04/07/2009 | US7514090 Monocyte locomotion inhibitory factor |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | WO2009042668A2 Urea-containing peptides as inhibitors of viral replication |
| 04/02/2009 | WO2009002203A8 Polyfunctional fullerene c60 aminoacid derivatives |
| 04/02/2009 | WO2008122794A3 Breast cancer methods, medicaments and agents |
| 04/02/2009 | WO2008108649A3 Ace-inhibitory peptides from whey and methods for providing the same. |
| 04/02/2009 | US20090088573 Biologically active peptides and compositions, their use |
| 04/02/2009 | US20090088553 Bis-Sulfhydryl Macrocyclization Systems |
| 04/02/2009 | US20090088390 Polypeptide |
| 04/02/2009 | US20090088384 Therapeutic Fibrin-Derived Peptides And Uses Thereof |
| 04/02/2009 | CA2700383A1 Urea-containing peptides as inhibitors of viral replication |
| 04/01/2009 | EP2041159A1 Macrocyclic compounds as antiviral agents |
| 04/01/2009 | EP2041158A2 Peptide epoxyketones for proteasome inhibition |
| 04/01/2009 | EP2041157A1 Peptide derivatives with therapeutic activity |
| 04/01/2009 | EP2041156A1 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 04/01/2009 | EP2040732A1 New use of therapeutically useful peptides |
| 04/01/2009 | EP1835926A4 Plasmin-inhibitory therapies |
| 04/01/2009 | CN101400691A Tropolone- and hydroxybenzene-substituted oligopeptides for depigmentation |
| 04/01/2009 | CN101400368A Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 03/31/2009 | US7511117 Compositions and methods for treating HIV infection with cupredoxin and cytochrome c |
| 03/31/2009 | US7511039 Thrombin inhibitors; protease inhibition, kinase inhibition, CAAX inhibition, interference with peptides binding to SH2 domains and inhibition of MCH-I and/or MHC II presentation of peptides to T cell receptors |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/26/2009 | WO2009039361A2 Process for the preparation of (s)-2-(3-tert-butylureido)-3,3-dimethylbutanoic acid |
| 03/26/2009 | WO2009037592A2 Triazole-based aminoglycoside-peptide conjugates and methods of use |
| 03/26/2009 | US20090082566 Di- and tri-peptide mono- and di-esters of acyclovir and gancyclovir and derivatives; esters have sufficient hydrophilicity to be formulated into pharmacologically active compositions such as aqueous solutions, eye drops; treating herpes simplex types 1, 2, varicella zoster virus, human cytomegalovirus |
| 03/26/2009 | US20090082283 Dipeptides for Prevention of Muscle Breakdown and Microbial Infection |
| 03/26/2009 | US20090082281 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/26/2009 | US20090082261 Urea-containing peptides as inhibitors of viral replication |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | CA2687689A1 Triazole-based aminoglycoside-peptide conjugates and methods of use |
| 03/25/2009 | EP2038295A1 Pseudo proline dipeptides |
| 03/25/2009 | EP2037942A2 Polymeric biosurfactants |
| 03/25/2009 | EP1583713B1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 03/24/2009 | US7507791 Coupling of arginine, proline and glycine on a solid phase support in presence of a first coupling agent/additive system, wherein the solid phase support is a 2-chlorotritylchloride-polystyrene resin; tosylation with 4-toluenesulfonyl chloride, cleavage of tosylated peptide; reacting with aniline |
| 03/24/2009 | US7507790 Plurality of peptide monomers each being attached at one end to a hub capable of interacting with a sub-unit of a self-assembling peptide to form an overlapping staggered structure or protein; purification of blood or biological fluids, cell assembly and tissue engineering |
| 03/24/2009 | US7507788 Peptides and methods for cell death regulation |
| 03/24/2009 | US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | US7507406 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 03/24/2009 | CA2223911C The preparation of active peptides |
| 03/19/2009 | WO2009035169A1 Peptide having anti-hypertensive activity |
| 03/19/2009 | WO2008096276A3 Peptide inhibitors of metallo- ectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses |
| 03/19/2009 | US20090076176 Prodrugs activated by plasmin and their use in cancer chemotherapy |
| 03/19/2009 | US20090075907 Synthetic peptide amides |
| 03/19/2009 | US20090075904 Protein Hydrolysate Enriched In Peptides Inhibiting DPP-IV And Their Use |
| 03/19/2009 | US20090075901 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/19/2009 | US20090075869 HCV NS3 protease inhibitors |
| 03/19/2009 | US20090075334 screening for a compound to change binding of ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; drug screening; used in treating HIV infection, cancer, and various other diseases and disorders |
| 03/19/2009 | US20090074828 Poly(amino acid) targeting moieties |
| 03/19/2009 | US20090074802 Immunomodulating oligopeptides |
| 03/19/2009 | US20090074664 Cyclic azapeptides as integrin markers |
| 03/18/2009 | EP2036924A2 Gene regulatory peptides |
| 03/18/2009 | EP2036920A1 Cycloalkylcarbonylamino acid ester derivative and process for producing the same |
| 03/18/2009 | EP2036919A1 Method for purification of oligopeptide |
| 03/18/2009 | EP2036918A1 Peptide derivative |
| 03/18/2009 | EP2035444A2 Dipeptide compounds containing d-histidine |
| 03/18/2009 | EP2035443A1 Stabilized vitamin c derivatives having a peptide molecule, preparation method thereof, and composition containing the same |
| 03/18/2009 | EP1907015A4 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 03/18/2009 | EP1581262B1 Contrast agent |
| 03/18/2009 | CN101389599A Modified amino acids |
| 03/18/2009 | CN100469787C Method for the synthesis of derivatives of (2S,3AS,7AS)-1-[(S)-1-alanyl]-octahydro-1H-indole-2-carboxylic acid and use thereof for the synthesis of perindopril |
| 03/18/2009 | CN100469779C Inhibitors of interleukin-1beta converting enzyme |
| 03/17/2009 | US7504383 metal at least partially enclosed by a discrete tubular, nanostructure composed of a plurality of aromatic homodipeptides |
| 03/17/2009 | US7504378 Viricides; induction immunology response; compounds according to invention specifically inhibit NS3 protease and do not show significant inhibitory activity against other serine proteases such as human leukocyte elastase, porcine pancreatic elastase, bovine pancreatic chymotrypsin, or cysteine proteases |
| 03/17/2009 | US7504092 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
| 03/12/2009 | WO2009033024A1 Biologically active c-terminal arginine-containing peptides |
| 03/12/2009 | WO2009030410A1 Improvements in or relating to compositions for the treatment or prophylaxis of viral infections |
| 03/12/2009 | US20090069537 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer |
| 03/12/2009 | US20090069428 Catalytic antioxidants and methods of use |
| 03/12/2009 | US20090069248 Substrate peptide sequences for plague plasminogen activator and uses thereof |
| 03/12/2009 | US20090068719 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 03/12/2009 | US20090068679 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof |
| 03/12/2009 | US20090068148 Peptides of cav2.2 that inhibit pain |
| 03/12/2009 | CA2697519A1 Biologically active c-terminal arginine-containing peptides |
| 03/12/2009 | CA2695960A1 Vegfr-1/nrp-1 targeting peptides |
| 03/11/2009 | EP2033654A1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/11/2009 | EP2032596A1 Neuroprotective compounds and uses thereof |
| 03/11/2009 | EP2032595A1 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application |
| 03/11/2009 | EP1819332B1 Pyrrolopyridine-2-carboxylic acid amides |
| 03/11/2009 | EP1699558B1 Removal of ruthenium by-product by supercritical fluid processing |
| 03/11/2009 | EP1613294B1 Peptides and derivatives thereof as inhibitors of oxidative damage of the skin |
| 03/11/2009 | EP1447409B1 Crystal of oxidized glutathione and process for producing the same |
| 03/11/2009 | EP1302476B1 Reduced fk228 and use thereof |
| 03/11/2009 | CN101381401A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 03/11/2009 | CA2638354A1 Association of an anti-atherothrombotic and an angiotensin converting enzyme inhibitor |
| 03/10/2009 | US7501485 Wound heraling agents; polypeptide |
| 03/10/2009 | US7501398 Peptide; HIV-1 PR inhibitors which effectively interferes with the folding mechanism of the protein itself, thus destabilizing it and making it prone to proteolysis; acquired immune deficiency syndrome |
| 03/05/2009 | WO2009027369A1 Method for selectively modifying a protein |
| 03/05/2009 | WO2009026729A1 Amino acid pairing-based self assembling peptides and methods |
| 03/05/2009 | WO2009026614A1 Hypoglycaemic tripeptide and methods of use thereof |
| 03/05/2009 | US20090062235 Inhibitors of Dipeptidylpeptidase IV |
| 03/05/2009 | US20090062186 Compounds Binding To P-Selectin |
| 03/05/2009 | US20090061014 Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | CA2697951A1 Amino acid pairing-based self assembling peptides and methods |
| 03/04/2009 | EP2031076A1 Novel compositions and methods for cancer |